
Organic Process Research and Development p. 670 - 685 (2020)
Update date:2022-08-04
Topics:
Hardouin, Christophe
Baillard, Sandrine
Barière, Fran?ois
Craquelin, Anthony
Grandjean, Mathieu
Janvier, Solenn
Le Roux, Stéphane
Penloup, Christine
Russo, Olivier
This paper describes the synthesis of kilogram quantities of the sulfonamide moiety 3 involved in a coupling reaction with acid moiety 2 to provide batches of drug candidate 1 for preclinical studies and first-in-human clinical trials. A first approach relying on a chiral separation furnished the desired enantiomer of 1,3-diamine 20, precursor of sulfonamide 3. An enantiomeric synthesis of 20 using the Ellman's chiral auxiliary coupled with an aza-Reformatsky reaction to control the stereochemistry is also discussed. Coupling conditions of the final step involving EDCI to provide 1 under a cGMP process are detailed. An alternative approach using N-(1-methanesulfonyl)benzotriazole is also presented.
View MoreShijiazhuang Yunxuan Im&Export Co.,Ltd.
Contact:+86-311-83037514
Address:No.6 Hongbin Road
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Changsha Huajing Powdery Material Technological Co., Ltd.
Contact:86-731-88879686
Address:Building 2, West Garden, Main Campus of Central South University, Changsha, Hunan Province, China
Penglai Qianwei Chemical Co., Ltd.
Contact:86-535-3357802
Address:Shahelu (north), Penglai, Shandong, China
Yancheng Creator Chemical Co., Ltd
Contact:0086-515-88710008 88710068 88710858 88710868
Address:No.21 Renming Road, Longgang Town, Yandu County,Yancheng City
Doi:10.1016/j.jorganchem.2008.04.023
(2008)Doi:10.1016/S0040-4039(00)95115-3
(1985)Doi:10.1039/c39860000757
(1986)Doi:10.1002/chem.201501823
(2015)Doi:10.1039/c1gc15701a
(2011)Doi:10.1002/jhet.5570450420
(2008)